Positive note on www.egoli.com.au as well today.
Waiting for the perfect storm.
• For Elders to generate underlying earnings growth of +12.8% in a market in which competitor Landmark is looking for a 25-30% fall in its earnings is an indication of the strength of the franchise and managements vision to move the business towards financial services (now 43% of earnings).
• Over the last three years we have seen compound earnings growth in Elders of 19% pa and that is in the face of two consecutive poor seasons. Under normal conditions Citigroup Investment Research (CIR) estimate that this business is capable of delivering a result $10-15m higher than it has in FY06.
• While MIS contributions are unlikely to grow in FY07e, an improvement in the sawmill operations through cost initiatives ($3.0m pa), no reoccurrence of redundancies ($0.8m) and a move to improve quality to stem customer losses look to set this business up for growth.
• With underlying EBIT lower than expected in most divisions, CIR have pulled back their NPAT forecasts by 2.1% in FY07e and 4.1% in FY08e. Their target price has come back to $2.34ps (prev. $2.46ps) principally on higher net debt and lower cash contributions from associates.
• FCL appears to be victim of a swing in sentiment towards forestry and agricultural stocks yet continues to demonstrate earnings growth. CIR continue to see solid earnings growth with compound EPS growth forecast at 13% through to FY09e at the very affordable FY07e P/E of 9.4x (pre-investments/property) and have retained their Buy/ Medium Risk (1M) rating.
- Forums
- ASX - By Stock
- cheaper than issue price.
FCL
fineos corporation holdings plc
Add to My Watchlist
0.43%
!
$2.29

Positive note on www.egoli.com.au as well today.Waiting for the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.29 |
Change
-0.010(0.43%) |
Mkt cap ! $775.1M |
Open | High | Low | Value | Volume |
$2.23 | $2.35 | $2.23 | $709.7K | 309.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 785 | $2.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.30 | 13937 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 785 | 2.250 |
1 | 7000 | 2.200 |
3 | 5476 | 2.100 |
2 | 2000 | 2.080 |
1 | 2415 | 2.070 |
Price($) | Vol. | No. |
---|---|---|
2.300 | 13937 | 1 |
2.350 | 14742 | 4 |
2.380 | 4000 | 1 |
2.480 | 225 | 1 |
2.490 | 20000 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
FCL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online